Clinical Trials
2 trialsNCT03277209 2020-03-02
To Assess the Safety of Continuous IV Administration of Plerixafor and Assess Impact on the Immune Microenvironment in Patients With Pancreatic, Ovarian and Colorectal Adenocarcinomas
Weill Medical College of Cornell University
Phase 1 Terminated
NCT02179970 2019-07-23
CAM-PLEX
Cambridge University Hospitals NHS Foundation Trust
Phase 1 Completed